-
Mashup Score: 0Type 2 diabetes predictors may identify worse long-term HbA1c - 1 year(s) ago
Data from previous HbA1c levels, fasting plasma glucose, duration of type 2 diabetes and diabetes medication use may predict long-term glycemic profile, researchers reported in Clinical Epidemiology. “Individualized prediction models based on [a] patient’s characteristics are needed to aid physicians and health care professionals in identification of the patients with poor treatment
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Mediating effect of vascular risk factors underlying the link between gestational diabetes and cardiovascular disease - BMC Medicine - 2 year(s) ago
Background Women with gestational diabetes (GDM) have an elevated lifetime incidence of cardiovascular disease (CVD), but the basis of this excess risk remains to be established. In this context, we hypothesized that chronic exposure to adverse cardiovascular risk factors may contribute to their elevated risk of CVD. We thus sought to quantify the determinants of CVD risk in women with a history…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
"Adverse #glycemic and #lipid measures mediate the elevated risk of #CVD in women with previous gestational #diabetes" New from @UofT - https://t.co/BmqtarFJwe #cardiotwitter #endotwitter #ObGynTwitter https://t.co/hJ6jdOYW16
-
-
Mashup Score: 1'Artificial Pancreas' Best in Poorly Controlled Type 1 Diabetes - 2 year(s) ago
Improvements compared to usual care of multiple daily insulin injections and intermittently scanned CGM were larger than those seen in prior trials of hybrid closed-loop systems.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
In adults with poorly controlled #T1D, the Medtronic 780G "artificial pancreas" system improves #glycemic control compared with multiple daily injections of insulin + isCGM, new data suggest. https://t.co/CqIRVfuJkK
-
-
Mashup Score: 0Glytec, CPS collaborate on glycemic management support - 2 year(s) ago
Glytec announced today that CPS Solutions selected it to serve as an insulin management technology resource.
Source: Drug Delivery BusinessCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@Glytec CPS collaborate on #glycemic management support for #pharmacy departments | #diabetes #insulin https://t.co/gQGfhasXNu
-
-
Mashup Score: 0Food insecurity drives poor glycemic control - 2 year(s) ago
Regardless of diet quality, diabetes patients with food insecurity were significantly more likely to have higher hemoglobin A1c than were those with food security.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
People with diabetes who had a poor-quality diet and food insecurity were significantly more likely to have poor #glycemic and #cholesterol control than were those with a healthier diet and food security. https://t.co/VvFNQ7cpsk #ADA2022 https://t.co/TIB30bl1Wk
-
-
Mashup Score: 1ENDO 2022 | June 11-14, 2022 - 2 year(s) ago
Be inspired by experts and stay at the forefront of scientific discovery and high-quality patient care.
Source: endo2022.endocrine.orgCategories: Endocrinology, Latest HeadlinesTweet-
Our Ancillary Symposia sessions are free for everyone! Explore topics like #obesity management, #glycemic control, and pediatric #achondroplasia. Visit our #ENDO2022 Registration Portal, navigate to Virtual Registration, and click Ancillary Events Only: https://t.co/vGxFzH9v7I
-
-
Mashup Score: 0
Background Dietary modifications are crucial for managing newly diagnosed type 2 diabetes mellitus (T2DM) and preventing its health complications, but many patients fail to achieve clinical goals with diet alone. We sought to evaluate the clinical effects of a personalized postprandial-targeting (PPT) diet on glycemic control and metabolic health in individuals with newly diagnosed T2DM as…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
A dietary intervention pilot trial investigating the effects of personalized diets by prediction of #glycemic responses on glycemic control and #Metabolic Health in newly-diagnosed T2DM. @segal_eran@EranElinav Read it here: https://t.co/7uKdyzxFK3 https://t.co/uBAqXswC8A
-
-
Mashup Score: 1
Show notes In this episode, Kristin Gusack interviews Dr. Rayhan Lal, an Instructor of Pediatrics in Endocrinology and Diabetes and an Instructor of Medicine in Endocrinology, Gerontology and Metabolism at Stanford Hospital and Clinics and Lucile Packard Children’s Hospital in Stanford, California….explores best practices for using telemedicine to provide optimal type 2 diabetes management…
Categories: Endocrinology, Latest HeadlinesTweet-
#Diabetes Management Through #Telehealth | Listen to the @mli_ace podcast where Rayhan Lal, MD explores best practices for using #telemedicine to provide optimal #T2D management including addressing #glycemic control, #bloodpressure control, and more: https://t.co/MgsMzZH5IY
-
-
Mashup Score: 0Real-World Evidence Shows Automated Insulin Dosing Safe, Effective Treatment for T1D - 3 year(s) ago
Investigators noted that several types of AID systems improved Time-in-Range and HbA1c with minimal concerns around severe hypoglycemia in type 1 diabetes care.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
Real-world studies on automated insulin dosing systems, along with their effects on #glycemic outcomes are a beneficial in evaluating their safety and effectiveness in #T1D care. https://t.co/rVg3FzNomF
-
-
Mashup Score: 2Metformin Use and Risk of Asthma Exacerbation Among Asthma Patients with Glycemic Dysfunction - 3 year(s) ago
Diabetes is associated with worse asthma morbidity. Metformin, which treats diabetes, may have a role among patients with asthma and glycemic dysfunction.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! #Metformin Use and Risk of #Asthma #Exacerbation Among #Asthma #Patients with #Glycemic #Dysfunction https://t.co/5Hwnf3FCGW https://t.co/g2F9seY7P5
-
Utilizing data from previous #HbA1c levels, fasting plasma glucose, duration of #diabetes and diabetes medication use may predict heterogeneity in long-term #glycemic control for adults with type 2 diabetes. @uef_farmasia https://t.co/Nhxx4lPxzt